Lars Viktrup

11PUBLICATIONS
26CO-AUTHORS
Traditional Chinese medicine and treatmentsCharacterisation of biological macromoleculesMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)Orthoptics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 29, 2025
Treatment effectiveness of galcanezumab versus traditional oral migraine preventive medications at 3 months: Results from the TRIUMPH study.

Richard B Lipton, Miguel J A Láinez, Zubair Ahmed

|Apr 03, 2025
Patient Preferences for Episodic Migraine Medications: A Discrete Choice Experiment of Self-Injectable Versus Oral Treatments Targeting Calcitonin Gene-Related Peptide Pathway.

Chiara Whichello, Lars Viktrup, Oralee J Varnado

|Mar 06, 2025
Treatment Patterns and Healthcare Resource Utilization by Gender and Migraine Frequency in Adult Patients Receiving Galcanezumab Versus Standard of Care Preventive Medications Over 24 months: A United States Retrospective Claims Study.

Oralee J Varnado, Michelle Vu, Erin K Buysman

|Aug 18, 2022
Efficacy and safety of tanezumab, NSAIDs, and placebo in patients with moderate to severe hip or knee osteoarthritis and a history of depression, anxiety, or insomnia: post-hoc analysis of phase 3 trials.

Philip Mease, Louis Kuritzky, Wendy L Wright

|May 19, 2022
Impact of osteoarthritis disease severity on treatment patterns and healthcare resource use: analysis of real-world data.

P G Conaghan, L Abraham, L Viktrup

|Mar 02, 2022
WOMAC Meaningful Within-patient Change: Results From 3 Studies of Tanezumab in Patients With Moderate-to-severe Osteoarthritis of the Hip or Knee.

Philip G Conaghan, Robert H Dworkin, Thomas J Schnitzer

Pageof 2

Frequent Collaborators

4 joint publications

Joseph C Cappelleri

3 joint publications

James Jackson

2 joint publications

Philip G Conaghan

2 joint publications

Lucy Abraham